Annual FCF
-$314.56 M
-$202.00 K-0.06%
December 31, 2023
Summary
- As of February 12, 2025, AGIO annual free cash flow is -$314.56 million, with the most recent change of -$202.00 thousand (-0.06%) on December 31, 2023.
- During the last 3 years, AGIO annual FCF has fallen by -$9.70 million (-3.18%).
- AGIO annual FCF is now -1198.06% below its all-time high of $28.65 million, reached on December 31, 2016.
Performance
AGIO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$84.64 M
-$11.89 M-16.34%
September 30, 2024
Summary
- As of February 12, 2025, AGIO quarterly free cash flow is -$84.64 million, with the most recent change of -$11.89 million (-16.34%) on September 30, 2024.
- Over the past year, AGIO quarterly FCF has dropped by -$11.89 million (-16.34%).
- AGIO quarterly FCF is now -154.57% below its all-time high of $155.09 million, reached on June 30, 2016.
Performance
AGIO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$330.11 M
-$5.13 M-1.58%
September 30, 2024
Summary
- As of February 12, 2025, AGIO TTM free cash flow is -$330.11 million, with the most recent change of -$5.13 million (-1.58%) on September 30, 2024.
- Over the past year, AGIO TTM FCF has dropped by -$5.13 million (-1.58%).
- AGIO TTM FCF is now -553.96% below its all-time high of $72.72 million, reached on June 30, 2016.
Performance
AGIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
AGIO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | -16.3% | -1.6% |
| 3 y3 years | -3.2% | +0.6% | +11.8% |
| 5 y5 years | -1.0% | +3.4% | +13.7% |
AGIO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.1% | +23.9% | -27.7% | +15.8% | -10.0% | +20.1% |
| 5 y | 5-year | -3.2% | +23.9% | -69.4% | +30.5% | -10.0% | +20.1% |
| alltime | all time | -1198.1% | +23.9% | -154.6% | +30.5% | -554.0% | +20.1% |
Agios Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$84.64 M(+16.3%) | -$330.11 M(+1.6%) |
| Jun 2024 | - | -$72.75 M(-27.3%) | -$324.99 M(+1.9%) |
| Mar 2024 | - | -$100.01 M(+37.5%) | -$318.99 M(+1.4%) |
| Dec 2023 | -$314.56 M(+0.1%) | -$72.72 M(-8.5%) | -$314.56 M(+2.1%) |
| Sep 2023 | - | -$79.51 M(+19.1%) | -$308.12 M(+2.7%) |
| Jun 2023 | - | -$66.75 M(-30.2%) | -$299.99 M(-3.0%) |
| Mar 2023 | - | -$95.58 M(+44.2%) | -$309.40 M(-1.6%) |
| Dec 2022 | -$314.36 M(-23.9%) | -$66.28 M(-7.2%) | -$314.36 M(-6.6%) |
| Sep 2022 | - | -$71.39 M(-6.3%) | -$336.68 M(-3.9%) |
| Jun 2022 | - | -$76.16 M(-24.3%) | -$350.45 M(-10.6%) |
| Mar 2022 | - | -$100.54 M(+13.5%) | -$391.84 M(-5.1%) |
| Dec 2021 | -$413.06 M(+35.5%) | -$88.59 M(+4.0%) | -$413.06 M(+10.3%) |
| Sep 2021 | - | -$85.16 M(-27.5%) | -$374.43 M(+3.2%) |
| Jun 2021 | - | -$117.54 M(-3.5%) | -$362.67 M(+14.4%) |
| Mar 2021 | - | -$121.76 M(+143.7%) | -$317.07 M(+4.0%) |
| Dec 2020 | -$304.87 M(-20.3%) | -$49.96 M(-31.9%) | -$304.87 M(-14.2%) |
| Sep 2020 | - | -$73.41 M(+2.0%) | -$355.20 M(-3.8%) |
| Jun 2020 | - | -$71.94 M(-34.3%) | -$369.41 M(-4.5%) |
| Mar 2020 | - | -$109.55 M(+9.2%) | -$386.89 M(+1.1%) |
| Dec 2019 | -$382.65 M(+22.9%) | -$100.29 M(+14.5%) | -$382.65 M(+7.0%) |
| Sep 2019 | - | -$87.63 M(-2.0%) | -$357.60 M(+6.1%) |
| Jun 2019 | - | -$89.42 M(-15.1%) | -$336.95 M(+6.5%) |
| Mar 2019 | - | -$105.31 M(+40.0%) | -$316.28 M(+1.6%) |
| Dec 2018 | -$311.41 M | -$75.24 M(+12.3%) | -$311.41 M(-0.2%) |
| Sep 2018 | - | -$66.98 M(-2.6%) | -$311.90 M(-3.9%) |
| Jun 2018 | - | -$68.76 M(-31.5%) | -$324.66 M(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$100.43 M(+32.6%) | -$315.92 M(+9.0%) |
| Dec 2017 | -$289.86 M(-1111.8%) | -$75.73 M(-5.0%) | -$289.86 M(+8.7%) |
| Sep 2017 | - | -$79.73 M(+32.8%) | -$266.57 M(+11.4%) |
| Jun 2017 | - | -$60.02 M(-19.3%) | -$239.29 M(+889.7%) |
| Mar 2017 | - | -$74.37 M(+41.8%) | -$24.18 M(-184.4%) |
| Dec 2016 | $28.65 M(-129.5%) | -$52.45 M(-0.0%) | $28.65 M(-40.8%) |
| Sep 2016 | - | -$52.46 M(-133.8%) | $48.38 M(-33.5%) |
| Jun 2016 | - | $155.09 M(-819.9%) | $72.72 M(-181.5%) |
| Mar 2016 | - | -$21.54 M(-34.2%) | -$89.27 M(-8.1%) |
| Dec 2015 | -$97.11 M(+57.7%) | -$32.72 M(+16.4%) | -$97.11 M(+31.8%) |
| Sep 2015 | - | -$28.11 M(+307.3%) | -$73.66 M(+5.8%) |
| Jun 2015 | - | -$6.90 M(-76.5%) | -$69.64 M(+9.0%) |
| Mar 2015 | - | -$29.38 M(+217.2%) | -$63.90 M(+3.8%) |
| Dec 2014 | -$61.57 M(+6.7%) | -$9.26 M(-61.6%) | -$61.57 M(-6.9%) |
| Sep 2014 | - | -$24.09 M(+1982.5%) | -$66.14 M(+15.8%) |
| Jun 2014 | - | -$1.16 M(-95.7%) | -$57.13 M(-21.2%) |
| Mar 2014 | - | -$27.05 M(+95.5%) | -$72.49 M(+25.6%) |
| Dec 2013 | -$57.69 M(+13.1%) | -$13.84 M(-8.2%) | -$57.69 M(+3.9%) |
| Sep 2013 | - | -$15.08 M(-8.7%) | -$55.51 M(+4.8%) |
| Jun 2013 | - | -$16.52 M(+34.8%) | -$52.97 M(+12.0%) |
| Mar 2013 | - | -$12.26 M(+5.2%) | -$47.28 M(-7.3%) |
| Dec 2012 | -$51.02 M(+197.9%) | -$11.65 M(-7.1%) | -$51.02 M(+29.6%) |
| Sep 2012 | - | -$12.54 M(+15.8%) | -$39.37 M(+46.7%) |
| Jun 2012 | - | -$10.83 M(-32.3%) | -$26.83 M(+67.7%) |
| Mar 2012 | - | -$15.99 M | -$15.99 M |
| Dec 2011 | -$17.13 M | - | - |
FAQ
- What is Agios Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual FCF year-on-year change?
- What is Agios Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly FCF year-on-year change?
- What is Agios Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM FCF year-on-year change?
What is Agios Pharmaceuticals annual free cash flow?
The current annual FCF of AGIO is -$314.56 M
What is the all time high annual FCF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual free cash flow is $28.65 M
What is Agios Pharmaceuticals annual FCF year-on-year change?
Over the past year, AGIO annual free cash flow has changed by -$202.00 K (-0.06%)
What is Agios Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of AGIO is -$84.64 M
What is the all time high quarterly FCF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly free cash flow is $155.09 M
What is Agios Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, AGIO quarterly free cash flow has changed by -$11.89 M (-16.34%)
What is Agios Pharmaceuticals TTM free cash flow?
The current TTM FCF of AGIO is -$330.11 M
What is the all time high TTM FCF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM free cash flow is $72.72 M
What is Agios Pharmaceuticals TTM FCF year-on-year change?
Over the past year, AGIO TTM free cash flow has changed by -$5.13 M (-1.58%)